...
首页> 外文期刊>Telemedicine and e-health: the official journal of the American Telemedicine Association >Randomized, Open-Label, Parallel Group Study to Evaluate the Effect of Internet-Based Glucose Management System on Subjects with Diabetes in China
【24h】

Randomized, Open-Label, Parallel Group Study to Evaluate the Effect of Internet-Based Glucose Management System on Subjects with Diabetes in China

机译:评估基于互联网的葡萄糖管理系统对中国糖尿病患者疗效的随机,开放标签,平行分组研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: Large amounts of time and effort are needed to implement an Internet-based glucose monitoring system (IBGMS) in the clinical setting. This study was designed using research experience that was developed while implementing an IBGMS in Korea, and the research platform was modified to evaluate the efficacy of an IBGMS in controlling blood sugar in the Chinese population. Methods: A randomized, open-label, parallel group design was used to evaluate the efficacy of an IBGMS among Chinese subjects with type 2 diabetes. Over a 6-month period, 182 subjects were evaluated in theIBGMS(n= 92) or control (n = 90) groups. Results: After 3 months, the control group's HbA1c levels were reduced from 8.0%-0.8% to 7.3%-1.2% (p < 0.001) and the IBGMS group experienced a reduction from 7.9%-0.8% to 6.9%-0.7% (p < 0.001); the IBGMS group's end value was significantly lower (p = 0.014). The intragroup changes in the control and IBGMS groups were significant at the 3-month (p = 0.002) and 6-month (p < 0.01) follow-ups. Over this period, the HbA1c levels in the control group increased slightly (7.3% - 1.1% to 7.4% - 1.3%, p = 0.605), and the HbA1c levels in the IBGMS group decreased slightly (6.9% - 0.7% to 6.7%-0.7%, p = 0.081). Conclusions: The IBGMS was effective in improving blood sugar levels among patients with diabetes. Therefore, IBGMS experience can be effectively transferred between institutions and countries.
机译:目的:在临床环境中实施基于Internet的葡萄糖监测系统(IBGMS)需要大量时间和精力。本研究是根据在韩国实施IBGMS时积累的研究经验设计的,并修改了研究平台以评估IBGMS在控制中国人群血糖方面的功效。方法:采用随机,开放标签,平行分组设计评估IBGMS在中国2型糖尿病患者中的疗效。在6个月的时间里,对IBGMS(n = 92)或对照组(n = 90)组的182名受试者进行了评估。结果:3个月后,对照组的HbA1c水平从8.0%-0.8%降低到7.3%-1.2%(p <0.001),而IBGMS组经历了从7.9%-0.8%降低到6.9%-0.7%(p p <0.001); IBGMS组的终值显着降低(p = 0.014)。在3个月(p = 0.002)和6个月(p <0.01)的随访中,对照组和IBGMS组的组内变化显着。在此期间,对照组的HbA1c水平略有增加(7.3%-1.1%至7.4%-1.3%,p = 0.605),IBGMS组的HbA1c水平则略有下降(6.9%-0.7%至6.7%) -0.7%,p = 0.081)。结论:IBGMS可有效改善糖尿病患者的血糖水平。因此,IBGMS经验可以在机构和国家之间有效地转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号